Universal screening for Hepatitis C in pregnant women
Universal HCV screening in pregnancy: Examining testing uptake and HCV care
This study is looking at how well universal Hepatitis C testing during pregnancy is working, especially for women who use drugs, to see if more pregnant women are getting tested and if it helps both them and their babies get the care they need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11047092 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of universal Hepatitis C virus (HCV) screening during pregnancy, particularly focusing on women who inject drugs. It aims to assess whether recent guidelines recommending universal testing have led to increased testing rates among pregnant women and improved care for both mothers and their infants. By analyzing national Medicaid and commercial claims data, the study will evaluate the impact of these guidelines on HCV testing, treatment, and the identification of infants at risk for perinatal transmission. The goal is to ensure that more women receive the necessary care and that infants born to HCV-infected mothers are appropriately tested and treated.
Who could benefit from this research
Good fit: Ideal candidates for this research include pregnant women, particularly those who inject drugs or are at risk for HCV infection.
Not a fit: Patients who are not pregnant or who do not have risk factors for HCV infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes for pregnant women and their infants by ensuring timely HCV testing and treatment.
How similar studies have performed: Previous research has shown that universal screening approaches can significantly improve health outcomes in similar populations, indicating potential success for this initiative.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Kapadia, Shashi — Weill Medical Coll of Cornell Univ
- Study coordinator: Kapadia, Shashi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.